Nature of the Event

The document is a regulatory disclosure submitted to the National Stock Exchange of India Limited (NSE) and BSE Limited, pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. It summarizes the proceedings of the company's 41st Annual General Meeting (AGM).

AGM Details

The 41st Annual General Meeting (AGM) of Biofil Chemicals and Pharmaceuticals Limited was held on Wednesday, 23rd September, 2026.

  • Timing: The meeting commenced at 03:03 P.M. (IST) and concluded at 03:17 P.M. (IST), lasting 14 minutes.
  • Mode: The meeting was conducted through Video Conference (VC) / Other Audio Visual Means (OAVM).
  • Venue: The Registered Office at B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.) was deemed the venue.
  • Quorum: The requisite quorum was present.
  • Total Members: 25,125 members as of the cutoff date, 16th September, 2026.
  • Members Present: 42 members attended the meeting through VC/OAVM.

Attendees

Directors and Key Managerial Personnel (KMPs) Present:

1. Mr. Ketan Shah - Chairman & Managing Director

2. Mr. Meet Shah - Non Executive Director

3. Mr. Smitesh Shah - Non Executive Director

4. Mr. Ashok Kumar Ramawat - Independent Director

5. Mr. Satish Beohar - Independent Director

6. Mrs. Gayatri Padiyar - Independent Director (Chairperson of Audit, NRC and SRC Committee)

7. Mr. Apoorv Jain - Company Secretary and Compliance Officer

8. Mr. Pavan Singh Rajput - Chief Financial Officer

Other Attendees:

The Statutory Auditors, Secretarial Auditors, and the scrutinizer (Ms. Darshika Wankhede, Practicing Company Secretary) were also present at the Meeting through VC/OAVM.

Proceedings Summary

Mr. Apoorv Jain, Company Secretary & Compliance Officer, introduced the Directors and Senior Management Personnel present. He briefed members on participation rules, confirming the meeting was held in compliance with circulars from the Ministry of Corporate Affairs (MCA) and SEBI. The requirement for appointing proxies was not applicable except for authorized representatives of corporate shareholders.

The Registers required under the Companies Act, 2013, and other relevant documents were available for inspection in electronic mode.

Remote e-voting commenced at 9:00 A.M. (IST) on Sunday, 20th September, 2026, and concluded at 5:00 P.M. (IST) on Tuesday, 22nd September, 2026.

Mr. Ketan Shah, Chairman and Managing Director, delivered opening remarks on the company's performance for the fiscal year 2026 and its future positioning.

Members were invited to raise queries. A total of four registrations were received from members wishing to speak, but only one registered speaker raised queries during the meeting. The company committed to responding to these queries via email.

The Company Secretary confirmed that the Notice for the 41st AGM and the Annual Report for FY26 were circulated electronically. The Reports of the Statutory Auditor contained no qualifications or adverse remarks. Observations by the secretarial auditor were noted as self-explanatory and not adversely affecting the company's functioning.

Business Transacted

The following items of business, as per the Notice dated 11th August, 2026, were transacted:

| Item No. | Details of Agenda Items | Resolution Type |

| 1. | To consider and adopt the Audited Financial Statements of the Company together with the Report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026. | Ordinary |

| 2. | To appoint a Director in place of Mr. Smitesh Shah (DIN: 00326182) who retires by rotation and is eligible for re-appointment. | Ordinary |

| 3. | Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director on attaining the age of 75 years. | Special |

| 4. | Approval of Material Related Party Transaction(s) with Cyano Pharma Private Limited. | Ordinary |

Voting Process

Voting for the resolutions was conducted via:

1. Remote e-voting (from 20th to 22nd September 2026).

2. E-voting during the AGM for members present via VC/OAVM who had not voted remotely.

Ms. Darshika Wankhede, Practicing Company Secretary, was appointed as the scrutinizer for the remote e-voting process and e-voting during the AGM.

Post-AGM Compliance

The company will submit the voting results in the SEBI-specified format along with the Scrutinizer's Report within the time limit prescribed under Regulation 44(3) of the SEBI (LODR) Regulations, 2015.

#Tags: #BiofilChemicals #AGM #SEBIDisclosure #RegulatoryCompliance #Neutral